[Effects of cardiac glycosides and aglycones on the sufficient heart].
D000293:Adolescent; D000328:Adult; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology*; D004071:Digitalis Glycosides / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010101:Oxygen Consumption; D011311:Pressoreceptors / Q000187:drug effects; D011433:Propranolol / Q000008:administration & dosage; D013328:Strophanthins / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects
D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D013328:Strophanthins; D010042:Ouabain; D011433:Propranolol
Die Wirkung von herzwirksamen Glykosiden und Aglykonen am suffizienten Herzen.